Snowflake Score | |
---|---|
Valuation | 1/6 |
Future Growth | 4/6 |
Past Performance | 0/6 |
Financial Health | 2/6 |
Dividends | 1/6 |
Life Science REIT plc Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | UK£0.40 |
52 Week High | UK£0.77 |
52 Week Low | UK£0.37 |
Beta | 0.13 |
1 Month Change | 5.57% |
3 Month Change | -29.43% |
1 Year Change | -44.88% |
3 Year Change | n/a |
5 Year Change | n/a |
Change since IPO | -60.40% |
Recent News & Updates
Recent updates
Shareholder Returns
LABS | GB Health Care REITs | GB Market | |
---|---|---|---|
7D | 1.8% | 1.9% | 1.0% |
1Y | -44.9% | -14.4% | 3.0% |
Return vs Industry: LABS underperformed the UK Health Care REITs industry which returned -13.6% over the past year.
Return vs Market: LABS underperformed the UK Market which returned 3.5% over the past year.
Price Volatility
LABS volatility | |
---|---|
LABS Average Weekly Movement | 4.0% |
Health Care REITs Industry Average Movement | 2.7% |
Market Average Movement | 4.8% |
10% most volatile stocks in GB Market | 11.4% |
10% least volatile stocks in GB Market | 2.7% |
Stable Share Price: LABS's share price has been volatile over the past 3 months.
Volatility Over Time: LABS's weekly volatility (4%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
n/a | n/a | Simon Farnsworth | www.lifesciencereit.co.uk |
Life Science REIT plc Fundamentals Summary
LABS fundamental statistics | |
---|---|
Market cap | UK£139.30m |
Earnings (TTM) | -UK£21.71m |
Revenue (TTM) | UK£19.94m |
7.0x
P/S Ratio-6.4x
P/E RatioIs LABS overvalued?
See Fair Value and valuation analysisEarnings & Revenue
LABS income statement (TTM) | |
---|---|
Revenue | UK£19.94m |
Cost of Revenue | UK£6.12m |
Gross Profit | UK£13.83m |
Other Expenses | UK£35.53m |
Earnings | -UK£21.71m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | -0.062 |
Gross Margin | 69.33% |
Net Profit Margin | -108.85% |
Debt/Equity Ratio | 38.0% |
How did LABS perform over the long term?
See historical performance and comparison